Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma

NCT01302886 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
41
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals